The difference in NCDs metabolic risk factors’ prevalence between the two surveys. by Mehran Asadi-Aliabadi (8383110)

Decrease of flowrate over time during plankton filtrations due to increased biomass loading of the filters, as recorded by the Arduino flowmeter (A), and (B) DNA yields after extra... by Corentin Fournier (5088941)

Forest plot displaying <i>Strongyloides stercoralis</i> prevalence before and after the intervention (assessment with fecal tests), stratified by number of ivermectin rounds. by Giacomo Stroffolini (11716410)

Subjects:

Prevalence of significant associations between the pre and post-treatment clinical and ECG/Holter findings in 106 patients with acute Chagas disease acquired by the oral route, Cha... by Raiza Ruiz-Guevara (17108737)

Subjects:

Variations in the prevalence of OASI in France between 2010 and 2021 according to the classification for episiotomy practices. by Raphaele Houlbracq (20558509)

Subjects:

Variations in the prevalence of episiotomy in France between 2010 and 2021 according to the classification for episiotomy practices. by Raphaele Houlbracq (20558509)

Subjects:

The receiver operating characteristic curve (ROC) for using ucfDNA molecules with a size range of 130 to 160 bp within the DHSs to distinguish control subjects with hematuria from... by Meihui Chen (1670020)

Subjects:

Heatmap showing the end motifs of ucfDNA among different groups. by Meihui Chen (1670020)

Subjects:

Analysis of ucfDNA in DHSs between control and age-comparable bladder cancer groups. by Meihui Chen (1670020)

Subjects:

ROC analysis for differentiating bladder cancer patients from controls using the ucfDNA concentration before and after normalization by creatinine concentration in those samples wi... by Meihui Chen (1670020)

Subjects:

Size distributions of ucfDNA molecules. by Meihui Chen (1670020)

Subjects:

Relationship of motif rankings in ucfDNA between WT and nuclease deficient mice. by Meihui Chen (1670020)

Subjects:

DNA concentrations of ucfDNA across WT, <i>Dnase1l3</i>^-/- and <i>Dnase1</i>^<i>-/-</i> mice with quantifiable ucfDNA using Qubit assay. by Meihui Chen (1670020)

Subjects:

Overview of the study design. by Meihui Chen (1670020)

Subjects:

The end density of ucfDNA across different tissue types. by Meihui Chen (1670020)

Subjects:

End density of the ucfDNA fragments within the DHSs. by Meihui Chen (1670020)

Subjects:

Percentages of ucfDNA fragments starting with T. by Meihui Chen (1670020)

Subjects:

Comparison of <i>DNASE1</i> mRNA expression levels in bladder tumoral tissues (n = 41) and adjacent non-tumoral tissues (n = 19) using the TCGA dataset. by Meihui Chen (1670020)

Subjects:

S8 Fig - by Meihui Chen (1670020)

Subjects:

DNA concentrations of ucfDNA in WT, <i>Dnase1l3</i>^-/- and <i>Dnase1</i>^-/- mice. by Meihui Chen (1670020)

Subjects: